Ocean Biomedical (OCEAW) Stock Price, News & Analysis
Company Description
Ocean Biomedical (OTC Link: OCEAW) is classified in the Pharmaceutical Preparations sector.
OCEAW has declined 99.3% over the past year. Shares last traded at $0.0001.
For FY2024, Ocean Biomedical and diluted earnings per share of $-0.34.
This page collects what Stock Titan holds for OCEAW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ocean Biomedical (OCEAW) stock last closed at $0.0001. Over the past 12 months, the stock has lost 99.3%.
Latest News
Ocean Biomedical has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. View all OCEAW news →
SEC Filings
Financial Highlights
operating income reached -$3.8M. Diluted earnings per share stood at $-0.34. The company generated -$4.2M in operating cash flow. With a current ratio of 0.02, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Ocean Biomedical (OCEAW) currently stands at 1.2 thousand shares. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Ocean Biomedical (OCEAW) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 20733.1% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
OCEAW Company Profile & Sector Positioning
Ocean Biomedical (OCEAW) operates in the Pharmaceutical Preparations sector and is listed on the OTC Link.